Dicerna Pharmaceuticals
DRNA
#3947
Rank
HK$23.18 B
Marketcap
HK$297.53
Share price
0.00%
Change (1 day)
17,279.45%
Change (1 year)

Revenue for Dicerna Pharmaceuticals (DRNA)

Revenue in 2021 (TTM): HK$1.49 Billion

According to Dicerna Pharmaceuticals's latest financial reports the company's current revenue is HK$1.50 Billion. In 2020 the company made a revenue of HK$1.27 Billion an increase over the revenue in the year 2019 that were of HK$0.18 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dicerna Pharmaceuticals from 2017 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)HK$1.49 B17.17%
2020HK$1.27 B587.36%
2019HK$0.18 B287.05%
2018HK$48.07 M171.23%
2017HK$17.72 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Regulus Therapeutics
RGLS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$4.46 B 197.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$488.76 B 32,456.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$24.98 B 1,564.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$500.04 B 33,208.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$280.01 B 18,552.32%๐Ÿ‡บ๐Ÿ‡ธ USA